[HTML][HTML] Cardiac magnetic resonance imaging: the future is bright
K Seetharam, S Lerakis - F1000Research, 2019 - ncbi.nlm.nih.gov
Over the last 15 years, cardiovascular magnetic resonance (CMR) imaging has
progressively evolved to become an indispensable tool in cardiology. It is a non-invasive …
progressively evolved to become an indispensable tool in cardiology. It is a non-invasive …
[HTML][HTML] Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta …
GJH Snel, M van den Boomen, LM Hernandez… - Journal of …, 2020 - Elsevier
Background The clinical application of cardiovascular magnetic resonance (CMR) T 2 and T
2* mapping is currently limited as ranges for healthy and cardiac diseases are poorly …
2* mapping is currently limited as ranges for healthy and cardiac diseases are poorly …
Reproducibility and its confounders of CMR feature tracking myocardial strain analysis in patients with suspected myocarditis
K Fischer, OL Linder, SA Erne, AW Stark, SJ Obrist… - European …, 2022 - Springer
Objectives Cardiovascular magnetic resonance feature tracking (CMR-FT) is an emerging
technique for assessing myocardial strain with valuable diagnostic and prognostic potential …
technique for assessing myocardial strain with valuable diagnostic and prognostic potential …
[HTML][HTML] Cardiac magnetic resonance in recovering COVID-19 patients. Feature tracking and mapping analysis to detect persistent myocardial involvement
JU Ulloa, VM de Vega, OS Montañés, AÁ Vázquez… - IJC Heart & …, 2021 - Elsevier
Background Post-COVID-19 patients may incur myocardial involvement secondary to
systemic inflammation. Our aim was to detect possible oedema/diffuse fibrosis using cardiac …
systemic inflammation. Our aim was to detect possible oedema/diffuse fibrosis using cardiac …
Early T1 myocardial MRI mapping: value in detecting myocardial hyperemia in acute myocarditis
A Palmisano, G Benedetti, R Faletti, PMV Rancoita… - Radiology, 2020 - pubs.rsna.org
Background Hyperemia is a key component of acute myocarditis (AM). Early gadolinium
uptake because of myocardial hyperemia may be quantified by using T1 mapping. Purpose …
uptake because of myocardial hyperemia may be quantified by using T1 mapping. Purpose …
[HTML][HTML] Cardiovascular magnetic resonance in myocardial infarction with non-obstructive coronary arteries patients: A review
The diagnosis of myocardial infarction with non-obstructive coronary arteries (MINOCA)
necessitates documentation of an acute myocardial infarction (AMI), non-obstructive …
necessitates documentation of an acute myocardial infarction (AMI), non-obstructive …
Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy
T Liu, Y Gao, H Wang, Z Zhou, R Wang, SS Chang… - Heart, 2021 - heart.bmj.com
Objective To explore the association between three-dimensional (3D) cardiac magnetic
resonance (CMR) feature tracking (FT) right ventricular peak global longitudinal strain …
resonance (CMR) feature tracking (FT) right ventricular peak global longitudinal strain …
Quantification of myocardial deformation applying CMR-feature-tracking—All about the left ventricle?
T Lange, A Schuster - Current Heart Failure Reports, 2021 - Springer
Abstract Purpose of Review Cardiac magnetic resonance-feature-tracking (CMR-FT)-based
deformation analyses are key tools of cardiovascular imaging and applications in heart …
deformation analyses are key tools of cardiovascular imaging and applications in heart …
Short‐term changes in left and right ventricular cardiac magnetic resonance feature tracking strain following ferric carboxymaltose in patients with heart failure: A …
I Del Canto, E Santas, I Cardells, G Miñana… - Journal of the …, 2022 - Am Heart Assoc
Background The mechanisms explaining the clinical benefits of ferric carboximaltose (FCM)
in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and …
in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and …
Distinguishing cardiac amyloidosis and hypertrophic cardiomyopathy by thickness and myocardial deformation of the right ventricle
H Liu, P Bai, HY Xu, ZL Li, CC Xia… - Cardiology …, 2022 - Wiley Online Library
Objectives. To compare right ventricular thickness (RVT) and deformation of cardiac
amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) patients. Methods. Sixty CA …
amyloidosis (CA) and hypertrophic cardiomyopathy (HCM) patients. Methods. Sixty CA …